FTT0831c/FTL_0325 contributes to Francisella tularensis cell division, maintenance of cell shape, and structural integrity

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2935-2948

  Robertson, Gregory T ^a   Russo Case, Elizabeth Di ^b,c   Dobbs, Nicole ^a   Ingle, Christine ^a   Balaban, Murat ^a,d   Celli, Jean ^b,e   Norgard, Michael V ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

^e WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; FITO 831 C PROTEIN; LIPOPOLYSACCHARIDE; O ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL WALL; BACTERIAL GROWTH; CELL DIVISION; CELL MEMBRANE; CELL SHAPE; CELL STRUCTURE; CELL VIABILITY; FEMALE; FRANCISELLA TULARENSIS; GENE DELETION; GENE INACTIVATION; GENETIC COMPLEMENTATION; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SURFACE PROPERTY; TEMPERATURE DEPENDENCE;

ANIMALS; BACTERIAL PROTEINS; CELL SHAPE; FEMALE; FRANCISELLA TULARENSIS; GENE DELETION; GENE EXPRESSION REGULATION, BACTERIAL; GENETIC COMPLEMENTATION TEST; IMMUNITY, INNATE; MICE; MICE, INBRED C3H; TULAREMIA;

EID: 84903189122     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00102-14     Document Type: Article

References (49)

1. Foley JE, Nieto NC. 2009. Tularemia. Vet. Microbiol. 140:332-338.
2. McLendon MK, Apicella MA, Allen LA. 2006. Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu. Rev. Microbiol. 60:167-185. http://dx.doi.org/10.1146/annurev.micro.60.080805.142126.
3. Ellis J, Oyston PC, Green M, Titball RW. 2002. Tularemia. Clin. Microbiol. Rev. 15:631-646. http://dx.doi.org/10.1128/CMR.15.4.631-646.2002.
4. Celli J, Zahrt TC. 2013. Mechanisms of Francisella tularensis intracellular pathogenesis. Cold Spring Harbor Perspect. Med. 3:a010314. http://dx.doi.org/10.1101/cshperspect.a010314.
5. Broms JE, Sjostedt A, Lavander M. 2010. The role of the Francisella tularensis pathogenicity island in type VI secretion, intracellular survival, and modulation of host cell signaling. Front. Microbiol. 1:136. http://dx.doi.org/10.3389/fmicb.2010.00136.
6. Jones CL, Napier BA, Sampson TR, Llewellyn AC, Schroeder MR, Weiss DS. 2012. Subversion of host recognition and defense systems by Francisella spp. Microbiol. Mol. Biol. Rev. 76:383-404. http://dx.doi.org/10.1128/MMBR.05027-11.
7. Bosio CM, Bielefeldt-Ohmann H, Belisle JT. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178:4538-4547. http://dx.doi.org/10.4049/jimmunol.178.7.4538.
8. Crane DD, Ireland R, Alinger JB, Small P, Bosio CM. 2013. Lipids derived from virulent Francisella tularensis broadly inhibit pulmonary inflammation via Toll-like receptor 2 and peroxisome proliferator-activated receptor alpha. Clin. Vaccine Immunol. 20:1531-1540. http://dx.doi.org/10.1128/CVI.00319-13.
9. Hall JD, Woolard MD, Gunn BM, Craven RR, Taft-Benz S, Frelinger JA, Kawula TH. 2008. Infected-host-cell repertoire and cellular response in the lung following inhalation of Francisella tularensis Schu S4, LVS, or U112. Infect. Immun. 76:5843-5852. http://dx.doi.org/10.1128/IAI.01176-08.
10. Malik M, Bakshi CS, Sahay B, Shah A, Lotz SA, Sellati TJ. 2006. Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect. Immun. 74:3657-3662. http://dx.doi.org/10.1128/IAI.02030-05.
11. Mares CA, Ojeda SS, Morris EG, Li Q, Teale JM. 2008. Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect. Immun. 76: 3001-3010. http://dx.doi.org/10.1128/IAI.00215-08.
12. Weiss DS, Brotcke A, Henry T, Margolis JJ, Chan K, Monack DM. 2007. In vivo negative selection screen identifies genes required for Francisella virulence. Proc. Natl. Acad. Sci. U. S. A. 104:6037-6042. http://dx.doi.org/10.1073/pnas.0609675104.
13. Brotcke A, Weiss DS, Kim CC, Chain P, Malfatti S, Garcia E, Monack DM. 2006. Identification of MglA-regulated genes reveals novel virulence factors in Francisella tularensis. Infect. Immun. 74:6642-6655. http://dx.doi.org/10.1128/IAI.01250-06.
14. Hager AJ, Bolton DL, Pelletier MR, Brittnacher MJ, Gallagher LA, Kaul R, Skerrett SJ, Miller SI, Guina T. 2006. Type IV pili-mediated secretion modulates Francisella virulence. Mol. Microbiol. 62:227-237. http://dx.doi.org/10.1111/j.1365-2958.2006.05365.x.
15. Ulland TK, Janowski AM, Buchan BW, Faron M, Cassel SL, Jones BD, Sutterwala FS. 2013. Francisella tularensis live vaccine strain folate metabolism and pseudouridine synthase gene mutants modulate macrophage caspase-1 activation. Infect. Immun. 81:201-208. http://dx.doi.org/10.1128/IAI.00991-12.
16. Ulland TK, Buchan BW, Ketterer MR, Fernandes-Alnemri T, Meyerholz DK, Apicella MA, Alnemri ES, Jones BD, Nauseef WM, Sutterwala FS. 2010. Cutting edge: mutation of Francisella tularensis mviN leads to increased macrophage absent in melanoma 2 inflammasome activation and a loss of virulence. J. Immunol. 185:2670-2674. http://dx.doi.org/10.4049/jimmunol.1001610.
17. Huang MT, Mortensen BL, Taxman DJ, Craven RR, Taft-Benz S, Kijek TM, Fuller JR, Davis BK, Allen IC, Brickey WJ, Gris D, Wen H, Kawula TH, Ting JP. 2010. Deletion of ripA alleviates suppression of the inflammasome andMAPKby Francisella tularensis. J. Immunol. 185:5476-5485. http://dx.doi.org/10.4049/jimmunol.1002154.
18. Okan NA, Chalabaev S, Kim TH, Fink A, Ross RA, Kasper DL. 2013. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. mBio 4:e00638-00612.
19. Lindemann SR, Peng K, Long ME, Hunt JR, Apicella MA, Monack DM, Allen LA, Jones BD. 2011. Francisella tularensis Schu S4 O-antigen and capsule biosynthesis gene mutants induce early cell death in human macrophages. Infect. Immun. 79:581-594. http://dx.doi.org/10.1128/IAI.00863-10.
20. Peng K, Broz P, Jones J, Joubert LM, Monack D. 2011. Elevated AIM2-mediated pyroptosis triggered by hypercytotoxic Francisella mutant strains is attributed to increased intracellular bacteriolysis. Cell Microbiol. 13: 1586-1600. http://dx.doi.org/10.1111/j.1462-5822.2011.01643.x.
21. Singh A, Rahman T, Malik M, Hickey AJ, Leifer CA, Hazlett KR, Sellati TJ. 2013. Discordant results obtained with Francisella tularensis during in vitro and in vivo immunological studies are attributable to compromised bacterial structural integrity. PLoS One 8:e58513. http://dx.doi.org/10.1371/journal.pone.0058513.
22. Dabo SM, Confer AW, Quijano-Blas RA. 2003. Molecular and immunological characterization of Pasteurella multocida serotype A:3 OmpA: evidence of its role in P. multocida interaction with extracellular matrix molecules. Microb. Pathog. 35:147-157.
23. Ristow P, Bourhy P, da Cruz McBride FW, Figueira CP, Huerre M, Ave P, Girons IS, Ko AI, Picardeau M. 2007. The OmpA-like protein Loa22 is essential for leptospiral virulence. PLoS Pathog. 3:e97. http://dx.doi.org/10.1371/journal.ppat.0030097.
24. Serino L, Nesta B, Leuzzi R, Fontana MR, Monaci E, Mocca BT, Cartocci E, Masignani V, Jerse AE, Rappuoli R, Pizza M. 2007. Identification of a new OmpA-like protein in Neisseria gonorrhoeae involved in the binding to human epithelial cells and in vivo colonization. Mol. Microbiol. 64:1391-1403. http://dx.doi.org/10.1111/j.1365-2958.2007.05745.x.
25. Wang Y. 2002. The function of OmpA in Escherichia coli. Biochem. Biophys. Res. Commun. 292:396-401. http://dx.doi.org/10.1006/bbrc.2002.6657.
26. Bouveret E, Benedetti H, Rigal A, Loret E, Lazdunski C. 1999. In vitro characterization of peptidoglycan-associated lipoprotein (PAL)-peptidoglycan and PAL-TolB interactions. J. Bacteriol. 181:6306-6311.
27. Cascales E, Lloubes R. 2004. Deletion analyses of the peptidoglycanassociated lipoprotein Pal reveals three independent binding sequences, including a TolA box. Mol. Microbiol. 51:873-885.
28. Parsons LM, Lin F, Orban J. 2006. Peptidoglycan recognition by Pal, an outer membrane lipoprotein. Biochemistry 45:2122-2128. http://dx.doi.org/10.1021/bi052227i.
29. Gerding MA, Ogata Y, Pecora ND, Niki H, de Boer PA. 2007. The trans-envelope Tol-Pal complex is part of the cell division machinery and required for proper outer-membrane invagination during cell constriction in Escherichia coli. Mol. Microbiol. 63:1008-1025. http://dx.doi.org/10.1111/j.1365-2958.2006.05571.x.
30. Mahawar M, Atianand MK, Dotson RJ, Mora V, Rabadi SM, Metzger DW, Huntley JF, Harton JA, Malik M, Bakshi CS. 2012. Identification of a novel Francisella tularensis factor required for intramacrophage survival and subversion of innate immune response. J. Biol. Chem. 287: 25216-25229. http://dx.doi.org/10.1074/jbc.M112.367672.
31. Mahawar M, Rabadi SM, Banik S, Catlett SV, Metzger DW, Malik M, Bakshi CS. 2013. Identification of a live attenuated vaccine candidate for tularemia prophylaxis. PLoS One 8:e61539. http://dx.doi.org/10.1371/journal.pone.0061539.
32. Robertson GT, Child R, Ingle C, Celli J, Norgard MV. 2013. IglE is an outer membrane-associated lipoprotein essential for intracellular survival and murine virulence of type A Francisella tularensis. Infect. Immun. 81: 4026-4040. http://dx.doi.org/10.1128/IAI.00595-13.
33. Hazlett KR, Caldon SD, McArthur DG, Cirillo KA, Kirimanjeswara GS, Magguilli ML, Malik M, Shah A, Broderick S, Golovliov I, Metzger DW, Rajan K, Sellati TJ, Loegering DJ. 2008. Adaptation of Francisella tularensis to the mammalian environment is governed by cues which can be mimicked in vitro. Infect. Immun. 76:4479-4488. http://dx.doi.org/10.1128/IAI.00610-08.
34. Horton RM. 1995. PCR-mediated recombination and mutagenesis. SOEing together tailor-made genes. Mol. Biotechnol. 3:93-99.
35. Gallagher LA, McKevitt M, Ramage ER, Manoil C. 2008. Genetic dissection of the Francisella novicida restriction barrier. J. Bacteriol. 190: 7830-7837. http://dx.doi.org/10.1128/JB.01188-08.
36. Choi KH, Gaynor JB, White KG, Lopez C, Bosio CM, Karkhoff-Schweizer RR, Schweizer HP. 2005. A Tn7-based broad-range bacterial cloning and expression system. Nat. Methods 2:443-448. http://dx.doi.org/10.1038/nmeth765.
37. LoVullo ED, Molins-Schneekloth CR, Schweizer HP, Pavelka MS, Jr. 2009. Single-copy chromosomal integration systems for Francisella tularensis. Microbiology 155:1152-1163. http://dx.doi.org/10.1099/mic.0.022491-0.
38. LoVullo ED, Sherrill LA, Pavelka MS, Jr. 2009. Improved shuttle vectors for Francisella tularensis genetics. FEMS Microbiol. Lett. 291:95-102. http://dx.doi.org/10.1111/j.1574-6968.2008.01440.x.
39. Schneider CA, Rasband WS, Eliceiri KW. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9:671-675. http://dx.doi.org/10.1038/nmeth.2089.
40. Chong A, Wehrly TD, Nair V, Fischer ER, Barker JR, Klose KE, Celli J. 2008. The early phagosomal stage of Francisella tularensis determines optimal phagosomal escape and Francisella pathogenicity island protein expression. Infect. Immun. 76:5488-5499. http://dx.doi.org/10.1128/IAI.00682-08.
41. Radolf JD, Chamberlain NR, Clausell A, Norgard MV. 1988. Identification and localization of integral membrane proteins of virulent Treponema pallidum subsp. pallidum by phase partitioning with the nonionic detergent triton X-114. Infect. Immun. 56:490-498.
42. Dotson RJ, Rabadi SM, Westcott EL, Bradley S, Catlett SV, Banik S, Harton JA, Bakshi CS, Malik M. 2013. Repression of inflammasome by Francisella tularensis during early stages of infection. J. Biol. Chem. 288: 23844-23857. http://dx.doi.org/10.1074/jbc.M113.490086.
43. Checroun C, Wehrly TD, Fischer ER, Hayes SF, Celli J. 2006. Autophagy-mediated reentry of Francisella tularensis into the endocytic compartment after cytoplasmic replication. Proc. Natl. Acad. Sci. U. S. A. 103:14578-14583. http://dx.doi.org/10.1073/pnas.0601838103.
44. Chong A, Wehrly TD, Child R, Hansen B, Hwang S, Virgin HW, Celli J. 2012. Cytosolic clearance of replication-deficient mutants reveals Francisella tularensis interactions with the autophagic pathway. Autophagy 8:1342-1356. http://dx.doi.org/10.4161/auto.20808.
45. Kanistanon D, Hajjar AM, Pelletier MR, Gallagher LA, Kalhorn T, Shaffer SA, Goodlett DR, Rohmer L, Brittnacher MJ, Skerrett SJ, Ernst RK. 2008. A Francisella mutant in lipid A carbohydrate modification elicits protective immunity. PLoS Pathog. 4:e24. http://dx.doi.org/10.1371/journal.ppat.0040024.
46. Pyles RB, Jezek GE, Eaves-Pyles TD. 2010. Toll-like receptor 3 agonist protection against experimental Francisella tularensis respiratory tract infection. Infect. Immun. 78:1700-1710. http://dx.doi.org/10.1128/IAI.00736-09.
47. Rozak DA, Gelhaus HC, Smith M, Zadeh M, Huzella L, Waag D, Adamovicz JJ. 2010. CpG oligodeoxyribonucleotides protect mice from Burkholderia pseudomallei but not Francisella tularensis Schu S4 aerosols. J. Immune Based Ther. Vaccines 8:2. http://dx.doi.org/10.1186/1476-8518-8-2.
48. West TE, Pelletier MR, Majure MC, Lembo A, Hajjar AM, Skerrett SJ. 2008. Inhalation of Francisella novicida ΔmglA causes replicative infection that elicits innate and adaptive responses but is not protective against invasive pneumonic tularemia. Microbes Infect. 10:773-780. http://dx.doi.org/10.1016/j.micinf.2008.04.008.
49. Lewis K. 2000. Programmed death in bacteria. Microbiol. Mol. Biol. Rev. 64:503-514. http://dx.doi.org/10.1128/MMBR.64.3.503-514.2000.